Navigation Links
Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Senators Kennedy, Hutchison for Bipartisan Cancer Alert Act
Date:3/26/2009

WASHINGTON, March 26 /PRNewswire/ -- The Susan G. Komen for the Cure(R) Advocacy Alliance applauds the bipartisan efforts of Senators Edward Kennedy (D-MA) and Kay Bailey Hutchison (R-TX) to reignite the war on cancer with the introduction today of the 21st Century Cancer ALERT (Access to Life-saving Early Detection, Research and Treatment) Act.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

"It's been more than 35 years since our nation first declared war on cancer, and yet we are still facing a significant cancer crisis," said Ambassador Nancy G. Brinker, founder of Susan G. Komen for the Cure. "This bill is a key first step towards reigniting the war on cancer. We are especially pleased that this is a bipartisan effort, as cancer doesn't care what party you belong to. We must all work together and let nothing stand in the way of discovering and delivering the cures to cancer."

ALERT stands for Access to Life-saving Early Detection, Research and Treatment:

  • Early Detection -- The ALERT Act will place an emphasis on early detection and promote the discovery and development of biomarkers to detect cancers at the earliest possible stage when cancer is most treatable. The bill also has a particular focus on childhood, rare and high-mortality cancers.
  • Research -- The ALERT Act will strengthen the cancer research process by promoting public-private partnerships and collaboration between government agencies. The bill also has a focus on translational research so new discoveries and breakthroughs in the laboratory make their way to patients' bedsides as quickly as possible.
  • Treatment -- The ALERT Act will improve access to cancer care for underserved populations by expanding access to clinical trials, patient navigation services, and screening and treatment for colorectal cancer.

The Komen Advocacy Alliance noted that 40 percent of Americans will be diagnosed with cancer at some point in their lives, including approximately 1.4 million new cases this year alone. Cancer will claim the lives of more than a half million people this year - about 1,500 people a day.

"While the statistics are staggering, the stories behind these numbers are tragic, and should compel us into action," said Brinker. "It's time to unleash the amazing power of science, technology and medicine to discover new ways to detect cancer of any type as early as possible - earlier than we can currently imagine. As we do, we must also ensure that everyone has access to the screening and treatment options that exist today."

The Susan G. Komen for the Cure(R) Advocacy Alliance (KAA) is the nonpartisan voice for over 2.5 million breast cancer survivors and the people who love them. Our mission is to translate the Susan G. Komen for the Cure(R) promise to end breast cancer forever into action at all levels of government to discover and deliver the cures.


'/>"/>
SOURCE Susan G. Komen for the Cure(R) Advocacy Alliance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pangea3 LLC Donates Contract Management Services to Susan G. Komen for the Cure
2. Susan G. Komen for the Cure(R) Advocacy Alliance Supports Effort to Encourage Early Breast Health Education
3. Susan G. Komen for the Cure(R) Signs Lease at Pews Nonprofit Village
4. D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R)
5. Susan G. Komen for the Cure(R)s Founder, Nancy G. Brinker, Reengages With Organization Following Tenure as U.S. Chief of Protocol
6. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Gov. Sebelius for Secretary of Health and Human Services
7. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Obama for Commitment to Health Reform, Cancer Research, in Budget Blueprint
8. Susan Torroella Joins MEDEX Global Group as COO
9. Susan G. Komen for the Cure(R) Advocacy Alliance Responds to President Barack Obamas Address to Congress
10. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Congress for Including Health Care Assistance; Research in Economic Stimulus
11. Dr Pepper Snapple Group Product Goes Pink in Support of Susan G. Komen for the Cure(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower ... college students who have participated in the program every summer. The 2017 Serve, ... applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have ...
(Date:3/29/2017)... Rouge, Louisiana (PRWEB) , ... March 29, 2017 ... ... HeartBoost in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers ... at Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the ...
(Date:3/29/2017)... Mt. Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... her patients on early orthodontic treatment and accepting new pediatric patients, with or without ... can help young patients have a better orthodontic outcome and experience. When patients receive ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... Immunotherapy ... a growing number of cancers and is touted to be the next revolution in ... thus far, has been in the form of immune checkpoint inhibitors such as PD-1 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  The leader in accelerated orthodontics, ... Sam Daher , Manal Ibrahim , ... Couchat will be the featured microlecture presenters at the ... Association of Orthodontists (AAO) Annual Session, April 21-25, 2017. ... microlectures beginning daily at 11:20 a.m. On the opening ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
(Date:3/29/2017)... , March 29, 2017 ... a report, which provides an exhaustive study of ... study, nearly 242 companies are functional in this ... competitive. With the leading companies, such as GlaxoSmithKline ... LP, focusing aggressively on various marketing strategies to ...
Breaking Medicine Technology: